M. Sieber

2.4k citations

39 papers · 1.3k indexed · h-index 18

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Oncology top 5%
- Viral-associated cancers and disorders
- Cancer survivorship and care

Papers in ⓘ

Pathology and Forensic Medicine 22
- Lymphoma Diagnosis and Treatment 21
Pulmonary and Respiratory Medicine 15
- Lung Cancer Treatments and Mutations 15

Co-authors: Volker Diehl (21 shared papers)Andreas Josting (9 shared papers)Andreas Engert (7 shared papers)B. Lathan (4 shared papers)Hans Tesch (9 shared papers)P. Koch (4 shared papers)Christian Rudolph (2 shared papers)Bernd Dörken (2 shared papers)
Journals: Annals of Oncology (11 papers)Journal of Clinical Oncology (2 papers)Water Air and Soil Pollution Focus (1 paper)Journal of Membrane Science (1 paper)European Journal of Cancer (1 paper)
Partner nations: Germany Switzerland Netherlands

In The Last Decade

M. Sieber

38 papers receiving 1.2k citations

Peers

Countries citing papers authored by M. Sieber

Since Specialization

Citations

This map shows the geographic impact of M. Sieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sieber more than expected).

Fields of papers citing papers by M. Sieber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sieber. The network helps show where M. Sieber may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Sieber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Sieber Line = papers co-authored together M. Sieber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease Annals of Oncology ·Andreas Josting, Christian Rudolph, Marcel Reiser, MY Mapara, M. Sieber, Hartmut Kirchner, Bernd Dörken, Dieter K. Hossfeld, Volker Diehl, Andreas Engert	2002	149
2	Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment Annals of Oncology ·U. Rueffer, Kai Breuer, Andreas Josting, B. Lathan, M. Sieber, Oliver Manzke, F. Grotenhermen, Hans Tesch, Henning Bredenfeld, P. Koch, Hiltrud Nisters-Backes, Jennifer Moriatis Wolf, Andreas Engert, Volker Diehl	2001	131
3	Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG) Annals of Oncology ·Andreas Josting, Christian Rudolph, MY Mapara, J. Glossmann, M. Sieber, H. Kirchner, Bernd Dörken, D Hossfeld, Jens Kisro, Bernd Metzner, Wolfgang E. Berdel, Volker Diehl, Andreas Engert, M. Sienawski	2004	112
4	BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease Annals of Oncology ·Volker Diehl, M. Sieber, U. Rüffer, B. Lathan, Dirk Hasenclever, Michael Pfreundschuh, Markus Loeffler, D. Lieberz, P. Koch, Michael Adler, Hans Tesch	1997	104
5	Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG) European Journal of Cancer ·Jens Ulrich Rüffer, Hans‐Henning Flechtner, P. Tralls, Andreas Josting, M. Sieber, B. Lathan, Volker Diehl	2003	97
6	Deutsche Hodgkin-Lymphom-Studiengruppe (DHSG): 20 Jahre Diagnostik, Therapie und Nachsorge von Patienten mit Morbus Hodgkin Oncology Research and Treatment ·Sascha Ansén, Andreas Engert, Juergen Wolf, M. Sieber, U. Paulus, Volker Diehl	2001	67
7	BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection Annals of Oncology ·Pia Hartmann, U. Rehwald, Bernd Salzberger, Caspar Franzen, M. Sieber, A. Wöhrmann, Volker Diehl	2003	64
8	Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease Annals of Oncology ·Volker Diehl, Markus Loeffler, Michael Pfreundschuh, U. Ruehl, Dirk Hasenclever, Hiltrud Nisters-Backes, M. Sieber, Kirby L. Smith, Hans Tesch, Wilhelm Geilen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1995	56
9	14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group Journal of Clinical Oncology ·M. Sieber, Henning Bredenfeld, Andreas Josting, Thorsten Reineke, U. Rueffer, Tina Koch, R. Wendel Naumann, F. Boissevain, P. Koch, P. Worst, Martin Soekler, Hans Theodor Eich, H. K. Müller-Hermelink, Jeremy Franklin, U. Paulus, Juergen Wolf, Andreas Engert, Volker Diehl	2003	52
10	Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group Blood ·Hans Tesch, Volker Diehl, B. Lathan, Dirk Hasenclever, M. Sieber, U. Rüffer, Andreas Engert, Jeremy Franklin, Michael Pfreundschuh, K.P. Schalk, G Schwieder, Gerburg M. Wulf, Gottfried Dölken, P. Worst, P. Koch, N. Schmitz, U. Bruntsch, C. Tirier, Ulrich Müller, Markus Loeffler	1998	48
11	Coping Strategies and Course of Disease of Breast Cancer Patients Psychotherapy and Psychosomatics ·Claus Buddeberg, C. Roland Wolf, M. Sieber, Astrid Riehl‐Emde, A. Bergant, Raphaël Steiner, C. Landolt-Ritter, Dirk Richter	1991	44
12	Evaporation of alcohol/water mixtures through hydrophobic porous membranes Journal of Membrane Science ·Edith Hoffmann, D. Pfenning, Elke Philippsen, Petra Schwahn, M. Sieber, R. Wehn, D. Woermann, G. Wiedner	1987	42
13	Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage Hodgkin's Lymphoma: Final Results of the German Hodgkin's Lymphoma Study Group Trial HD5 Journal of Clinical Oncology ·M. Sieber	2002	38
14	Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group Annals of Oncology ·M. Sieber, Andreas Engert, Volker Diehl	2000	37
15	Quality of life assessment in Hodgkin’s disease: A new comprehensive approach Annals of Oncology ·Hans‐Henning Flechtner, Jens Ulrich Rüffer, M. Henry‐Amar, W. A. M. Mellink, M. Sieber, Christophe Fermé, Houchingue Eghbali, Andreas Josting, Volker Diehl	1998	27
16	Spleen involvement in Hodgkin's lymphoma: assessment and risk profile Annals of Hematology ·U. Rueffer, M. Sieber, M. Stemberg, A Goßmann, Andreas Josting, Teresa Koch, F. Grotenhermen, V. Diehl Not Available	2003	20
17	Treatment of Hodgkin's disease: Current strategies of the German Hodgkin's Lymphoma Study Group Annals of Oncology ·M. Sieber, U. Rüffer, A. Jostin, Volker Diehl	1999	19
18	A New and Sound Technology for Biogas from Solid Waste and Biomass Water Air and Soil Pollution Focus ·Günter Busch, J. Großmann, M. Sieber, Marko Burkhardt	2008	17
19	Enabling savings in silver consumption and poly-Si thickness by integration of plated Ni/Cu/Ag contacts for bifacial TOPCon solar cells Solar Energy Materials and Solar Cells ·Sven Kluska, R. Haberstoh, Benjamin Grübel, G. Cimiotti, Christian Schmiga, Andreas A. Brand, Andreas NÃgele, Bernd Steinhauser, Mathias Kamp, Michael Passig, M. Sieber, Damian Brunner, S. Fox	2022	15
20	Reliable Contact Formation for Industrial Solar Cells by Laser Ablation and Ni/Cu Plating EU PVSEC ·Niels Bay, Jörg Horzel, Michael Passig, M. Sieber, J. Burschik, H. Kühnlein, Jonas Bartsch, Andreas A. Brand, A. Mondon, D. Eberlein, C. Völker, Simon Gutscher, (unknown), B. Lee, D. Weber, R. Böhme	2014	14

About M. Sieber

M. Sieber is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Genetics, Oncology and Neurology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (15 papers), Silicon and Solar Cell Technologies (7 papers), Lung Cancer Research Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), solar cell performance optimization (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (794 citations), Oncology (603 citations), Neurology (324 citations), Genetics (170 citations) and Reproductive Medicine (113 citations). M. Sieber has collaborated with scholars based in Germany, Switzerland and Netherlands. Frequent co-authors include Volker Diehl, Andreas Josting, Andreas Engert, B. Lathan, Hans Tesch, P. Koch, Christian Rudolph, Bernd Dörken, MY Mapara and Andreas Engert. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Water Air and Soil Pollution Focus, Journal of Membrane Science and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact